Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diabetes

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    September 2019
  1. WILLIAMS ME
    Said the glucose sensor to the insulin pump: can glycemic control be improved in hospitalized ESRD patients with diabetes mellitus?
    Kidney Int. 2019;96:540-542.
    PubMed     Text format     Abstract available


    August 2019
  2. VAN BAAR MJB, Scholtes RA, van Raalte DH
    SGLT2 inhibitors' interaction with other renoactive drugs in type 2 diabetes patients: still a lot to learn.
    Kidney Int. 2019;96:283-286.
    PubMed     Text format     Abstract available


    July 2019
  3. KANDA E, Nangaku M
    Are SGLT2 inhibitors a targeted treatment for diabetic kidney disease?
    Kidney Int. 2019;96:8-10.
    PubMed     Text format    


    June 2019
  4. ZHANG D, Gava AL, Van Krieken R, Mehta N, et al
    The caveolin-1 regulated protein follistatin protects against diabetic kidney disease.
    Kidney Int. 2019 Jun 17. pii: S0085-2538(19)30618.
    PubMed     Text format     Abstract available


    May 2019
  5. BALMER LA, Whiting R, Rudnicka C, Gallo LA, et al
    Genetic characterization of early renal changes in a novel mouse model of diabetic kidney disease.
    Kidney Int. 2019 May 30. pii: S0085-2538(19)30510.
    PubMed     Text format     Abstract available


  6. KODAMA Y, Hyodo F, Yamato M, Yasukawa K, et al
    Dynamic nuclear polarization magnetic resonance imaging and the oxygen-sensitive paramagnetic agent OX63 provide a noninvasive quantitative evaluation of kidney hypoxia in diabetic mice.
    Kidney Int. 2019 May 24. pii: S0085-2538(19)30515.
    PubMed     Text format     Abstract available


  7. ROSSING P, Block GA, Chin MP, Goldsberry A, et al
    Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.
    Kidney Int. 2019 May 16. pii: S0085-2538(19)30503.
    PubMed     Text format     Abstract available


  8. CHO ME, Hansen JL, Peters CB, Cheung AK, et al
    An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30506.
    PubMed     Text format     Abstract available


  9. CASSIS P, Locatelli M, Corna D, Villa S, et al
    Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy.
    Kidney Int. 2019 May 10. pii: S0085-2538(19)30486.
    PubMed     Text format     Abstract available


    April 2019
  10. BARBOUR S, Djurdjev O, Gill JS, Dong JJ, et al
    A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.
    Kidney Int. 2019 Apr 1. pii: S0085-2538(19)30388.
    PubMed     Text format     Abstract available


    March 2019
  11. MAYER GJ, Wanner C, Weir MR, Inzucchi SE, et al
    Analysis from the EMPA-REG OUTCOME((R)) trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics.
    Kidney Int. 2019 Mar 21. pii: S0085-2538(19)30317.
    PubMed     Text format     Abstract available


  12. BALLY L, Gubler P, Thabit H, Hartnell S, et al
    Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30322.
    PubMed     Text format     Abstract available


  13. LAVOZ C, Matus YS, Orejudo M, Carpio JD, et al
    Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy.
    Kidney Int. 2019 Mar 8. pii: S0085-2538(19)30124.
    PubMed     Text format     Abstract available


  14. CHEN G, Chen H, Ren S, Xia M, et al
    Aberrant DNA methylation of mTOR pathway genes promotes inflammatory activation of immune cells in diabetic kidney disease.
    Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30273.
    PubMed     Text format     Abstract available


  15. SUNG CC, Chen L, Limbutara K, Jung HJ, et al
    RNA-Seq and protein mass spectrometry in microdissected kidney tubules reveal signaling processes initiating lithium-induced nephrogenic diabetes insipidus.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30267.
    PubMed     Text format     Abstract available


    February 2019
  16. XU H, Kuja-Halkola R, Chen X, Magnusson PKE, et al
    Higher body mass index is associated with incident diabetes and chronic kidney disease independent of genetic confounding.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30047.
    PubMed     Text format     Abstract available


  17. CHEN X, Han Y, Gao P, Yang M, et al
    Disulfide-bond A oxidoreductase-like protein protects against ectopic fat deposition and lipid-related kidney damage in diabetic nephropathy.
    Kidney Int. 2019 Feb 12. pii: S0085-2538(18)30899.
    PubMed     Text format     Abstract available


  18. STARUSCHENKO A
    TRPC6 in diabetic kidney disease: good guy or bad guy?
    Kidney Int. 2019;95:256-258.
    PubMed     Text format     Abstract available


    January 2019
  19. CANI PD
    Targeting gut microbiota with a complex mix of dietary fibers improves metabolic diseases.
    Kidney Int. 2019;95:14-16.
    PubMed     Text format    


    December 2018
  20. CHAUHAN K, Verghese DA, Rao V, Chan L, et al
    Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes.
    Kidney Int. 2018 Dec 20. pii: S0085-2538(18)30772.
    PubMed     Text format     Abstract available


  21. HIRAKAWA Y, Nangaku M
    Targeting oxidative stress in diabetic kidney disease: a novel drug in an old pathway.
    Kidney Int. 2018;94:1038-1039.
    PubMed     Text format    


    November 2018
  22. JIANG G, Luk AOY, Tam CHT, Xie F, et al
    Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes.
    Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30629.
    PubMed     Text format     Abstract available


    September 2018
  23. MICAKOVIC T, Papagiannarou S, Clark E, Kuzay Y, et al
    The angiotensin II type 2 receptors protect renal tubule mitochondria in early stages of diabetes mellitus.
    Kidney Int. 2018 Sep 3. pii: S0085-2538(18)30442.
    PubMed     Text format     Abstract available


    July 2018
  24. TANAKA S, Sugiura Y, Saito H, Sugahara M, et al
    Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice.
    Kidney Int. 2018 Jul 13. pii: S0085-2538(18)30353.
    PubMed     Text format     Abstract available


    June 2018
  25. BOMSZTYK K, Denisenko O, Wang Y
    DNA methylation yields epigenetic clues into the diabetic nephropathy of Pima Indians.
    Kidney Int. 2018;93:1272-1275.
    PubMed     Text format     Abstract available


    May 2018
  26. FU J, Wei C, Zhang W, Schlondorff D, et al
    Gene expression profiles of glomerular endothelial cells support their role in the glomerulopathy of diabetic mice.
    Kidney Int. 2018 May 31. pii: S0085-2538(18)30242.
    PubMed     Text format     Abstract available


  27. GROVE KJ, Lareau NM, Voziyan PA, Zeng F, et al
    Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney.
    Kidney Int. 2018 May 17. pii: S0085-2538(18)30202.
    PubMed     Text format     Abstract available


    February 2018
  28. HONG Q, Zhang L, Das B, Li Z, et al
    Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury.
    Kidney Int. 2018 Feb 22. pii: S0085-2538(18)30033.
    PubMed     Text format     Abstract available


  29. KOPP C, Linz P, Maier C, Wabel P, et al
    Elevated tissue sodium deposition in patients with type 2 diabetes on hemodialysis detected by (23)Na magnetic resonance imaging.
    Kidney Int. 2018 Feb 15. pii: S0085-2538(17)30857.
    PubMed     Text format     Abstract available


  30. NOWAK N, Skupien J, Smiles AM, Yamanouchi M, et al
    Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Kidney Int. 2018 Feb 2. pii: S0085-2538(17)30892.
    PubMed     Text format     Abstract available


  31. PERCO P, Mayer G
    Molecular, histological, and clinical phenotyping of diabetic nephropathy: valuable complementary information?
    Kidney Int. 2018;93:308-310.
    PubMed     Text format     Abstract available


    January 2018

  32. Zhang L, Zhang Q, Liu S, et al. DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury. Kidney Int. 2017;92:140-153.
    Kidney Int. 2018;93:271.
    PubMed     Text format    


    December 2017
  33. XIE Y, Bowe B, Li T, Xian H, et al
    Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus.
    Kidney Int. 2017 Dec 7. pii: S0085-2538(17)30676.
    PubMed     Text format     Abstract available


    October 2017
  34. NAIR V, Komorowsky CV, Weil EJ, Yee B, et al
    A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome.
    Kidney Int. 2017 Oct 18. pii: S0085-2538(17)30610.
    PubMed     Text format     Abstract available


  35. CHUN N, Wyatt CM, He JC
    Identification of a protective proteomic signature and a potential therapeutic target in diabetic nephropathy.
    Kidney Int. 2017;92:780-781.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: